A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency

Clinical trial NCT01407874 · COMPLETED

Trial details

NCT number: NCT01407874
Sponsor: BioCryst Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gout Hyperuricemia Arthritis Joint Disease Renal Insufficiency

Start date: 2011-09-01
Primary completion: 2012-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.